Want to join the conversation?
$SYK, which competes with $ZBH & $EW, said that 1Q16 adjusted GM rose 240 BP to 68%. Of this, roughly a quarter relates to the two-year suspension of the medical device tax, while the remainder reflects a favorable mix and favorable FX partly offset by negative pricing. Adjusted SG&A rose to 37.4% of sales vs. 35.9% in prior period.
$NFLX a monster move, going up. Expect making some money on Monday.
$AMD down more than 6% even after posting above consensus third quarter results.
$MCD stock rose more than 2% after it posted better than expected 3Q16 results, driven by global same-store sales growth. Meanwhile, earnings and revenue were lower than last year, hurt by refranchising efforts.